1Stock1.com

Celgene Corporation (CELG) Yearly Returns

Year	Beginning Price	Ending Price	Gain or Loss	Percent Gain or Loss
1988	8.75	9.125	0.375	4.29%
1989	9.125	7.50	-1.625	-17.81%
1990	7.50	6.50	-1.00	-13.33%
1991	6.50	15.25	8.75	134.62%
1992	15.25	13.125	-2.125	-13.93%
1993	13.125	7.00	-6.125	-46.67%
1994	7.00	5.625	-1.375	-19.64%
1995	5.625	13.375	7.75	137.78%
1996	13.375	11.125	-2.25	-16.82%
1997	11.125	8.4375	-2.6875	-24.16%
1998	8.4375	15.375	6.9375	82.22%
1999	15.375	70.00	54.625	355.28%
2000	70.00	97.50*	27.50	39.29%
2001	32.50	31.92	-0.58	-1.78%
2002	31.92	21.47	-10.45	-32.74%
2003	21.47	44.88	23.41	109.04%
2004	44.88	53.04*	8.16	18.18%
2005	26.52	64.80	38.28	144.34%
2006	64.80	115.06*	50.26	77.56%
2007	57.53	46.21	-11.32	-19.68%
2008	46.21	55.28	9.07	19.63%
2009	55.28	55.68	0.40	0.72%
2010	55.68	59.14	3.46	6.21%
2011	59.14	67.60	8.46	14.31%
2012	67.60	78.47	10.87	16.08%
2013	78.47	168.968	90.498	115.33%
2014	168.968	223.72*	54.752	32.40%
2015	111.86	119.76	7.90	7.06%
2016	119.76	115.75	-4.01	-3.35%
2017	115.75	104.36	-11.39	-9.84%
2018	104.36	64.09	-40.27	-38.59%
2019	64.09	124.19*	60.10	93.77%

*The 2000 ending price for Celgene has been adjusted for a 3 for 1 stock split.
*The 2004 ending price for Celgene has been adjusted for a 2 for 1 stock split.
*The 2006 ending price for Celgene has been adjusted for a 2 for 1 stock split.
*The 2014 ending price for Celgene has been adjusted for a 2 for 1 stock split.
*In 2019, Bristol-Myers Squibb (BMY) completed its acquisition of Celgene (CELG). CELG shareholders received 1 share of BMY and $60.00 in cash for every share of CELG held.

Calculations do not reflect any dividends paid or any stock spinoffs from original stock. Taxes and commissions are not factored into calculations. Data is property of 1stock1 and written permission must be granted before redistributing any data (in part or in whole).

Disclaimer/Contact Us

Stock Performance Guide         

Yearly Stock Returns Index     

Back to Yearly Stock Returns Index

Articles
From
1stock1.com